Cellectis SA(CLLS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

CLLS Cellectis SA

Trading 05-22 13:16:30 EDT

3.54

+0.02

+0.57%

High3.68	Low3.54	Vol10.23K
Open3.61	D1 Closing3.52	Amplitude3.92%
Mkt Cap357.54M	Tradable Cap236.86M	Total Shares101.00M
T/O36.68K	T/O Rate0.02%	Tradable Shares66.91M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"CLLS","market":"US","secType":"STK","nameCN":"Cellectis SA","latestPrice":3.54,"timestamp":1779470168125,"preClose":3.52,"halted":0,"volume":10232,"delay":0,"changeRate":0.005681818181818187,"floatShares":66909900,"shares":101000000,"eps":-0.670046,"marketStatus":"Trading","change":0.02,"latestTime":"05-22 13:16:30 EDT","open":3.61,"high":3.6781,"low":3.54,"amount":36681.090732,"amplitude":0.039233,"askPrice":3.55,"askSize":138,"bidPrice":3.52,"bidSize":19,"shortable":3,"etf":0,"ttmEps":-0.670046,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1779480000000},"marketStatusCode":2,"adr":1,"adrRate":1,"listingDate":1427256000000,"exchange":"NASDAQ","adjPreClose":3.52,"postHourTrading":{"tag":"盘后","latestPrice":3.52,"preClose":3.52,"latestTime":"16:04 EDT","volume":2,"amount":7.04,"timestamp":1779393887184,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.493404,"impliedVol":0.2735,"impliedVolPercentile":0.0558},"requestUrl":"/m/hq/s/CLLS/wiki","defaultTab":"wiki","newsList":[{"id":"2637736568","title":"Press Release: Cellectis' Annual Shareholders General Meeting to be Held on June 25, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2637736568","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637736568?lang=en_us&edition=fundamental","pubTime":"2026-05-21 04:30","pubTimestamp":1779309000,"startTime":"0","endTime":"0","summary":"NEW YORK, May 20, 2026  -- Cellectis  , a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, announced today that it will hold its annual general meeting on June 25, 2026 at 2:30 p.m. CET at the Biopark auditorium, 11 rue Watt, 4th floor, 75013 Paris, France.Cellectis is a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies. The company utilizes an allogeneic approach for CAR T immunotherapies in oncology, pioneering the concept of off-the-shelf and ready-to-use gene-edited CAR T-cells to treat cancer patients, and a platform to develop gene therapies in other therapeutic indications. With its in-house manufacturing capabilities, Cellectis is one of the few end-to-end gene editing companies that controls the cell and gene therapy value chain from start to finish.Cellectis' headquarters are in Paris, France, with locations in New York an","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CLLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636985076","title":"European Equities Traded in the US as American Depositary Receipts Trend Lower in Tuesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2636985076","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636985076?lang=en_us&edition=fundamental","pubTime":"2026-05-19 23:27","pubTimestamp":1779204425,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were trending lower late Tuesday morning, declining 0.3% to 1,824.16 on the S&P Europe Select ADR Index.From continental Europe, the ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BMPRXR70.SGD","BK4107","IE0002141913.USD","IE00BJJMRZ35.SGD","IEUR","SQNS","BK4547","IE00B2B36J28.USD","LNOK","BK4201","LU0300736492.USD","AUTL","LU2324357040.USD","EQNR","BK4117","CRTO","BK4009","IE0009355771.USD","IE0034235188.USD","BK4007","BK7511","IE00BFMHRM44.USD","SNN","IE00BJT1NW94.SGD","BK7095","BHP","BHP.AU","BDRX","BK4528","BK7507","SLN","EPV","AKTX","SAP","LU0109394709.USD","BK4168","AFG","BK4020","BK4588","EDAP","IE00BFTCPJ56.SGD","LU1983260115.SGD","BK4023","LU0889565916.HKD","BK4505","NCNA","NOK","BK4139","CLLS","ARGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635467777","title":"European Equities Traded in the US as American Depositary Receipts Tracking Higher in Thursday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2635467777","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635467777?lang=en_us&edition=fundamental","pubTime":"2026-05-14 23:04","pubTimestamp":1778771099,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were moving higher late Thursday morning, rising 0.43% to 1,852.92 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by semiconductor company Sequans Communications  and 3D printer company Materialise , which climbed 11.4% and 10.4% respectively. They were followed by lender ING Group  and biopharmaceutical company Cellectis , which increased 2.3% and 2.1% respectively.The decliners from continental Europe were led by pharmaceutical company Novo Nordisk  and internet browser company Opera , which fell 1.7% and 1.6% respectively. They were followed by oil and gas company Eni  and lender Banco Santander , which were off 1.3% and 0.5% respectively.The gainers from the UK were led by biopharmaceutical companies NuCana  and Akari Therapeutics , which advanced 9.6% and 3.2% respectively. They were followed by communications company WPP  and lender Barclays , which were up 2.8% and 2.4% respectiv","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7095","AMRN","LU1829250122.USD","BK4107","BK7141","BK4117","LU0154236417.USD","BK4568","LU0889565916.HKD","AKTX","BK4023","BK4009","LU2237443895.HKD","BK7505","LU0300736492.USD","NVO","BK4168","NVOH","SAN","LU0109394709.USD","BK4139","LU2237443465.HKD","AZN","LU2417539215.USD","BK7104","BK4141","BK7511","MTLS","LU2237443978.SGD","NCNA","LU0289739699.SGD","AUTL","BCS","BK7507","ING","BK4521","LU0320765992.SGD","LU2462157665.USD","E","BK4585","IE00BZ1G4Q59.USD","LU0058720904.USD","BK4207","LU2237443549.SGD","BHP","BK4546","BK4599","LU0300736062.USD","LU2456880835.USD","NVOX","LU1093756325.SGD","LU2237443622.USD","LU1093756168.USD","AZNH","BK4588","LU2236285917.USD","BK4532","BK7142","BK4201","SQNS","IE00B3T34201.USD","WPP","LU2237443382.USD","IE00BKVL7J92.USD","CLLS","BK4007","OPRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634436482","title":"European Equities Traded in the US as American Depositary Receipts Decline Sharply in Tuesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2634436482","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634436482?lang=en_us&edition=fundamental","pubTime":"2026-05-12 23:14","pubTimestamp":1778598868,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were down significantly late Tuesday morning, dropping 1.05% to 1,814.06 on the S&P Europe Select ADR Index.From continental Europe, ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BTI.AU","LU1829250122.USD","NOK","LU0162691827.USD","LU0072461881.USD","BK4585","OPRA","BK4142","DBVT","IE00BFMHRM44.USD","VOD","LU2543165471.USD","AKTX","CLLS","MREO","BK4132","IE00BMPRXN33.USD","LYG","BK4141","AFG","BK4207","SLN","BK4521","BK4077","BK4139","CRTO","LU0006061336.USD","LNOK","BK4075","BK4007","IEUR","GSK","IE00BMPRXR70.SGD","GSK.UK","BTI","BK4588","BK4117","BK4023","TRVG","BK4505","MTLS","SQNS","BK4107","CUK","BK4020","EPV","GSKH","BK7062","BK4546","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634217382","title":"Cellectis to Present Clinical Data on Lasme-cel and Eti-cel at EHA 2026 Annual Congress","url":"https://stock-news.laohu8.com/highlight/detail?id=2634217382","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634217382?lang=en_us&edition=fundamental","pubTime":"2026-05-12 21:30","pubTimestamp":1778592600,"startTime":"0","endTime":"0","summary":"NEW YORK, May  12, 2026  (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene editing platform to dev","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/12/3293001/0/en/Cellectis-to-Present-Clinical-Data-on-Lasme-cel-and-Eti-cel-at-EHA-2026-Annual-Congress.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1115378108.SGD","CLLS","BK4139","BK4006","TX","LU0640798160.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634256287","title":"Cellectis SA reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2634256287","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634256287?lang=en_us&edition=fundamental","pubTime":"2026-05-12 07:21","pubTimestamp":1778541707,"startTime":"0","endTime":"0","summary":"Cellectis SA reports results for the quarter ended March 31 - Earnings SummaryCellectis SA CLLS.OQ reported a quarterly adjusted loss of 18 cents per share for the quarter ended March 31, identical to","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nL8N41O2UD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLLS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634230698","title":"Cellectis Q1 Adj. EPS $(0.16) Beats $(0.27) Estimate, Sales $7.548M Miss $12.267M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2634230698","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634230698?lang=en_us&edition=fundamental","pubTime":"2026-05-12 04:32","pubTimestamp":1778531554,"startTime":"0","endTime":"0","summary":"Cellectis (NASDAQ:CLLS) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0.27) by 40.74 percent. This is a 5.88 percent increase over losses of $(0.17) per share from the same","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"11c8fbbf839f433c9d274cef5f173382","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52470067/cellectis-q1-adj-eps-0-16-beats-0-27-estimate-sales-7-548m-miss-12-267m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Cellectis Q1 Adj. EPS $(0.16) Beats $(0.27) Estimate, Sales $7.548M Miss $12.267M Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CLLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634230959","title":"Cellectis Reports Financial Results for the First Quarter 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2634230959","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634230959?lang=en_us&edition=fundamental","pubTime":"2026-05-12 04:30","pubTimestamp":1778531400,"startTime":"0","endTime":"0","summary":"Pivotal Phase 2 with lasme-cel in r/r B-ALL (BALLI-01 trial) Pivotal Phase 2 first interim analysis expected in Q4 2026BLA submission anticipated in 2028 Phase 1 with eti-cel in r/r NHL (NATHALI-01 tr","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/11/3292381/0/en/Cellectis-Reports-Financial-Results-for-the-First-Quarter-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4006","LU0963586101.USD","ORR","CLLS","IE00B66KJ199.SGD","BK4161","CR","BK4139","LU2065731478.USD","IE00B7SZL793.SGD","CRS","IE00B19Z4B17.USD","BK4187","IE0031619046.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634753238","title":"European Equities Traded in the US as American Depositary Receipts Start Week on Flat Note in Monday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2634753238","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634753238?lang=en_us&edition=fundamental","pubTime":"2026-05-11 23:05","pubTimestamp":1778511940,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts opened the week on a flat note Monday morning, edging 0.08% higher to 1,835.34 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by semiconductor company Sequans Communications  and biopharmaceutical company Cellectis , which advanced 8.1% and 6.3% respectively. They were followed by biopharmaceutical company DBV Technologies  and telecommunications company Ericsson , which increased 4.9% and 3.2% respectively.The decliners from continental Europe were led by consumer goods company Unilever  and biopharmaceutical company Grifols , which fell 1.9% and 1.3% respectively. They were followed by internet browser company Opera  and accommodations booking site trivago , which were down 1% each.The gainers from the UK were led by cruise line operator Carnival  and pharmaceutical company Silence Therapeutics , which rose 6.6% and 4.7% respectively. They were followed by biotech firm Autolus Therape","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0689626769.HKD","CUK","LU0124676726.USD","BK4141","BK4515","OPRA","AMRN","BK4020","BK4505","TRVG","BK4077","BK4007","LU0084288595.USD","BK4588","BK4554","AUTL","DAVA","DAVA.AU","EPV","BK4585","BK4107","LU0648005311.SGD","ULVR.UK","CLLS","UN","BK4117","BK4023","IEUR","SLN","BK4134","BK4183","ERIC","UL","DBVT","MREO","GRFS","SQNS","BK4142","AKTX","BK4592","BDRX","BK4139","AFG","BK4591"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634020034","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2634020034","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634020034?lang=en_us&edition=fundamental","pubTime":"2026-05-11 18:00","pubTimestamp":1778493600,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·ATL Braves C                                   1Q      (.78)   8:00 AM","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BODI","CVRX","ALLT","BRCB","CINT","BLNK","AMTM","AIP","ACM","ACHV","BIOA","ABOS","CERT","CBLL","B","ASTS","CRCL","DCGO","APC","ACET","CGBD","CEG","BCSF","BGS","ASRT","AMBQ","BATRK","AEYE","ANDG","APEI","ACRS","CLSK","ABCL","CHRS","BTAI","CDRE","CEVA","BALY","ARMK","ACH","CLLS","COOK","BATRA","ACXP","AGNT","BETA","ATRO","BCAX","ARVN","ALGS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634614465","title":"Cellectis SA  expected to post a loss of 26 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2634614465","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634614465?lang=en_us&edition=fundamental","pubTime":"2026-05-09 00:54","pubTimestamp":1778259247,"startTime":"0","endTime":"0","summary":"Cellectis SA  expected to post a loss of26cents a share - Earnings Preview Cellectis SA CLLS.OQ, CLLS.O is expected to  show a rise in quarterly revenue when it reports  results on May 11 for the peri","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nL8N41L25H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLLS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633434311","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2633434311","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633434311?lang=en_us&edition=fundamental","pubTime":"2026-05-08 18:00","pubTimestamp":1778234400,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·Alpha Metal Res                                  1Q      (.36)   7:30 AM. ·Plains All Am                                    1Q       .37    7:30 AM. ·Plains GP A                                     1Q       .46    7:30 AM","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APC","ESNT","AMTM","EMBJ","ALXO","ABCL","ACH","AMR","ANIP","ENTA","BAM","BATRK","CRCL","CLLS","APEI","FIGR","DCBO","DCGO","AMCX","FHTX","CNTY","CINT","AQN","ASTS","CVRX","ENB","CLMT","BATRA","CHRS","TM","CEVA","B","CBLL","EXPI","CDRE","EMA","BCSF","BTAI","BCAX","CEG","CLSK","AU","CGBD","ASRT","ACM","CERT","FIS","DDD","DCH","BLNK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633321931","title":"European Equities Traded in the US as American Depositary Receipts Climb Sharply Higher in Wednesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2633321931","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633321931?lang=en_us&edition=fundamental","pubTime":"2026-05-06 23:10","pubTimestamp":1778080223,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were tracking higher late Wednesday morning, rising 1.98% to 1,843.18 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by accommodations booking company trivago  and lender ING Group , which advanced 14% and 5% respectively. They were followed by biopharmaceutical company Cellectis  and lender Banco Santander , which climbed 4.8% and 4.2% respectively.The decliners from continental Europe were led by internet advertising firm Criteo  and petroleum refiner Equinor , which shed 18% and 8.4% respectively. They were followed by semiconductor company Sequans Communications  and oil and gas company Eni , which dropped 5.8% and 4.5% respectively.The gainers from the UK were led by biopharmaceutical company Akari Therapeutics  and insurance company Prudential , which rose 9.4% and 6.2% respectively. They were followed by mining company BHP Group  and lender Barclays , which were up 5.3% and 5.2% ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","DBE","DRLL","CLLS","NCNA","DRIP","AFG","LU0006061336.USD","BK4141","LU0162691827.USD","PUK","AKTX","VDE","LU0278409577.USD","SQNS","XES","BHP","DIG","BK4585","E","BK7142","EQNR","BPH","MREO","BK4207","ING.AU","TRVG","ING","USE","SAN","PXJ","BK4107","BCS","DBC","IXC","CRTO","IEO","LU1829250122.USD","BK4201","BHP.AU","BK4117","BP","GUSH","IEUR","SAN.AU","ERX","SHEH","SHEL","FTXN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633969363","title":"Cellectis to Report First Quarter Financial Results on May 11, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2633969363","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633969363?lang=en_us&edition=fundamental","pubTime":"2026-05-05 04:30","pubTimestamp":1777926600,"startTime":"0","endTime":"0","summary":"NEW YORK, May  04, 2026 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS- NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to devel","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/04/3287174/0/en/Cellectis-to-Report-First-Quarter-Financial-Results-on-May-11-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CLLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632951701","title":"European Equities Traded in the US as American Depositary Receipts Start Week Lower","url":"https://stock-news.laohu8.com/highlight/detail?id=2632951701","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632951701?lang=en_us&edition=fundamental","pubTime":"2026-05-04 23:09","pubTimestamp":1777907360,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts kicked off the week lower late Monday morning, falling 0.70% to 1,803.50 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by semiconductor company Sequans Communications  and biopharmaceutical company argenx , which climbed 8.1% and 1.9% respectively. They were followed by petroleum refiner Equinor  and biopharmaceutical company Grifols , which advanced 1.8% and 1.5% respectively.The decliners from continental Europe were led by pharmaceutical company Sanofi  and lender Banco Bilbao Vizcaya Argentaria , which dropped 5.5% and 4.2% respectively. They were followed by medical device maker EDAP TMS  and biopharmaceutical company Cellectis , which lost 3.3% and 1% respectively.The gainers from the UK were led by biopharmaceutical company Akari Therapeutics  and biotech firm Autolus Therapeutics , which rose 9.2% and 2.8% respectively. They were followed by biopharmaceutical companies Biodexa ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AMRN","LU1829250122.USD","BK4082","BK4107","BK4117","ARGX","BBVA","TRIB","LU0889565916.HKD","AKTX","LU2324357040.USD","IEUR","BK4505","BK4139","LU0109394709.USD","IE0034235188.USD","IE00BJJMRZ35.SGD","BDRX","BK4141","IE00BFTCPJ56.SGD","NCNA","AUTL","EDAP","IE00B4R5TH58.HKD","AFG","LU0320765992.SGD","IE00BFXG1179.USD","SNY","BK4585","GSK.UK","BK4142","BK4207","IE00BJT1NW94.SGD","IE0002141913.USD","IE0009355771.USD","EQNR","IE00B2B36J28.USD","BK4588","BK4532","GSKH","BK4201","GSK","SQNS","CUK","CLLS","BK4007","GRFS","LU1983260115.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632643568","title":"European Equities Traded in the US as American Depositary Receipts Flat in Friday Trading; Gain 1.3% for Week","url":"https://stock-news.laohu8.com/highlight/detail?id=2632643568","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632643568?lang=en_us&edition=fundamental","pubTime":"2026-05-01 23:10","pubTimestamp":1777648259,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were trending marginally higher late Friday morning, rising 0.05% to 1,824.45 on the S&P Europe Select ADR Index, which is up 1.25% f","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NVOX","LU0320765646.SGD","NTZ","NVO","LU0006061336.USD","BK4111","BNTX","LU2236285917.USD","BP","IE00BZ1G4Q59.USD","LU0278409577.USD","PXJ","IXC","BK4599","LU0098860793.USD","NOK","AMRN","PSO","BCYC","LU1162221912.USD","SHEL","GUSH","LU0124676726.USD","VDE","BK4095","BK4007","CLLS","BK4585","UL","BDRX","BPH","DBE","LU1829250122.USD","ULVR.UK","IEO","DRIP","BK4551","IE00BKVL7J92.USD","LU0300736492.USD","LU1093756325.SGD","EQNR","LU0162691827.USD","BK4204","LU0154236417.USD","IE00BMPRXR70.SGD","BK4183","DIG","UN","DRLL","BK4139","IE00BMPRXN33.USD","BK4588","LNOK","BK4547","BK4548","LU0072461881.USD","DBVT","BK4532","BK4117","ERX","BK4568","BK4107","BK4535","BK7104","LU1093756168.USD","BK4592","DBC","SHEH","BK4201","CUK","LU0300736062.USD","BK4142","USE","BK4020","NVOH","LU0689626769.HKD","AKTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631054666","title":"European Equities Traded in the US as American Depositary Receipts Lower in Wednesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2631054666","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631054666?lang=en_us&edition=fundamental","pubTime":"2026-04-29 23:05","pubTimestamp":1777475127,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were lower late Wednesday morning, declining 0.45% to 1,779.46 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by telecommunications firm Nokia  and medical device maker EDAP , which rose 6.1% and 3.8% respectively. They were followed by petroleum refiner Equinor  and Banco Santander , which were up 2.7% and 1% respectively.The decliners from continental Europe were led by biopharmaceutical company Cellectis  and healthcare tech firm Royal Philips , which fell 6.1% and 5.6% respectively. They were followed by internet browser company Opera  and semiconductor company Sequans Communications , which lost 3.2% and 3.1% respectively.The gainers from the UK were led by communications company WPP  and software firm Endava , which advanced 2.7% and 1.2% respectively. They were followed by oil and gas company Shell  and educational publisher Pearson , which increased 1% and 0.7% respectively.The ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LNOK","GSKH","LU0320765646.SGD","GSK.UK","SHEH","BK4207","BK4204","BK4588","CLLS","DAVA.AU","OPRA","BK4111","WPP","LU1829250122.USD","BK4521","BK4007","AKTX","BK7142","BK4532","LU2236285917.USD","BK4201","LU0300736062.USD","PSO","SAN","BK4020","LU1162221912.USD","DAVA","BK4117","SHEL","BK4107","MREO","BK4009","PHG","IE00BMPRXR70.SGD","EDAP","BK4139","GSK","LU0084288595.USD","LU0278409577.USD","SAN.AU","EQNR","AFG","WPP.AU","BK4082","SLN","BK4547","SQNS","NOK","LU0648005311.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630031087","title":"Cellectis Presents Epigenetic Editing Platform to Turn Genes Off Without Altering DNA at the ASGCT Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2630031087","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630031087?lang=en_us&edition=fundamental","pubTime":"2026-04-28 04:30","pubTimestamp":1777321800,"startTime":"0","endTime":"0","summary":"NEW YORK, April  27, 2026 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene editing platform to de","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/27/3282051/0/en/Cellectis-Presents-Epigenetic-Editing-Platform-to-Turn-Genes-Off-Without-Altering-DNA-at-the-ASGCT-Annual-Meeting.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0957791311.USD","LU1983260115.SGD","LU1815333072.USD","LU0096362180.USD","LU0345770993.USD","LU2506951958.HKD","IE00B1XK9C88.USD","LU0276348264.USD","LU1868837136.USD","LU0823434740.USD","IE00BJJMRX11.SGD","LU2417539215.USD","LU0316494557.USD","LU1084165304.USD","LU1261432733.SGD","LU1868836591.USD","LU2552382058.USD","LU0109391861.USD","LU1363072403.SGD","IE0004445015.USD","LU2168564149.EUR","LU0950375773.USD","LU2317271919.USD","BK4566","LU2168564495.EUR","LU0061474960.USD","LU2764263039.SGD","CLLS","LU0210533765.USD","LU2456880835.USD","LU2506951875.HKD","LU2552382132.HKD","LU0053666078.USD","IE0004086264.USD","LU2764262908.HKD","LU0077335932.USD","MA","LU0256863811.USD","LU0820562030.AUD","LU2756315318.SGD","LU1989772923.USD","LU1718418525.SGD","LU0390134368.USD","LU2461242641.AUD","LU2506952097.USD","LU0170899867.USD","LU0174119429.USD","BK4109","DNA","LU2168564065.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629237248","title":"European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2629237248","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629237248?lang=en_us&edition=fundamental","pubTime":"2026-04-24 23:23","pubTimestamp":1777044216,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were rising late Friday morning, gaining 0.66% at 1,798.36 on the S&P Europe Select ADR Index, which is off 2% for the week so far.From continental Europe, the gainers were led by pharmaceutical company Novo Nordisk  and software firm SAP , which rose 6.4% and 5.6% respectively. They were followed by furniture maker Natuzzi  and consumer goods company Unilever , which were up 2.6% and 1.7% respectively.The decliners from continental Europe were led by biotech firm Evaxion  and petroleum refiner Equinor , which fell 2.4% and 1.4% respectively. They were followed by biopharmaceutical company Cellectis  and oil and gas company Eni , which were down 1.2% and 0.9% respectively.The gainers from the UK were led by British American Tobacco  and InterContinental Hotels Group , which advanced 2.5% and 2.4% respectively. They were followed by insurance company Prudential  and educational publisher Pearson , which increased 1.2% an","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4599","IHG","BK4111","BK4613","LU0154236417.USD","BTI","UL","NVO","BK4082","E","LU2543165471.USD","LU1093756325.SGD","BK4592","BK4528","BK4007","BK7104","BK4139","NVOX","PSO","TRIB","NTZ","NVOH","IE00BZ1G4Q59.USD","LU0072461881.USD","UN","BK4585","BK4532","NCNA","ULVR.UK","BK4107","BK4162","CLLS","LU1093756168.USD","EVAX","BK4075","BK7062","EQNR","LU0689626769.HKD","BK4117","BK4023","IE00BKVL7J92.USD","BK4588","SAP","LU0162691827.USD","PUK","AUTL","LU0006061336.USD","LU0124676726.USD","BK4142","02378","BK4204","BK4183","SLN","BK4201","BK4095"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628724604","title":"European Equities Traded in the US as American Depositary Receipts Decline in Monday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2628724604","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628724604?lang=en_us&edition=fundamental","pubTime":"2026-04-20 23:11","pubTimestamp":1776697897,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts started the week tracking lower late Monday morning, as the S&P Europe Select ADR Index was falling 0.54% to 1,830.11.From continenta","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0072461881.USD","LU0162691827.USD","SQNS","VOD","NOK","LNOK","SAN","AKTX","BK4075","BK4142","BK4007","SAN.AU","BK4515","BK4141","BK4554","BP","BK4521","NCNA","BBVA","LU1829250122.USD","BK7142","BK7062","AFG","LU0320765646.SGD","CUK","BDRX","BK4132","BPH","BK4020","BK4201","BK4591","BK4588","BK4547","BK4532","BTI","BK4117","ERIC","GRFS","IE00BMPRXN33.USD","LU1162221912.USD","OPRA","WPP","LU2543165471.USD","CLLS","BK4009","LU0006061336.USD","WPP.AU","BTI.AU","IE00BMPRXR70.SGD","BK4207"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cellectis.com","stockEarnings":[{"period":"1week","weight":-0.1351},{"period":"1month","weight":-0.12},{"period":"3month","weight":-0.0974},{"period":"6month","weight":-0.2495},{"period":"1year","weight":1.3158},{"period":"ytd","weight":-0.2727}],"compareEarnings":[{"period":"1week","weight":-0.0073},{"period":"1month","weight":0.0549},{"period":"3month","weight":0.0773},{"period":"6month","weight":0.127},{"period":"1year","weight":0.2743},{"period":"ytd","weight":0.0892}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Cellectis S.A., a clinical stage biotechnological company, develops products based on gene-editing with a portfolio of allogeneic chimeric antigen receptor T-cells product candidates. The company is developing ALLO-715 and ALLO-605 for the treatment of multiple myeloma; ALLO-501 to treat large B-cell lymphoma; ALLO-316, an allogeneic engineered CAR T-cell product targeting CD70; ALLO-819 to treat acute myeloid leukemia; ALLO-213 for the treatment of small cell lung cancer; and ALLO-182 to treat gastric and pancreatic cancer. It also develops UCART22 for the treatment of relapsed or refractory B-cell acute lymphoblastic leukemia; UCART123 to treat acute myeloid leukemia; UCART 20x22 for relapsed or refractory B-Cell non-hodgkin's lymphoma; and cema-cel to treat relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma. The company has strategic alliances with Allogene Therapeutics, Inc. and Les Laboratoires Servier; research collaboration and exclusive license agreement with Iovance Biotherapeutics, Inc.; and joint research and collaboration, and investment agreement with AstraZeneca Holdings B.V., as well as with AstraZeneca Ireland Limited. Cellectis S.A. was founded in 1999 and is headquartered in Paris, France.","yearOnYearQuotes":[{"month":1,"riseRate":0.454545,"avgChangeRate":-0.025762},{"month":2,"riseRate":0.454545,"avgChangeRate":-0.069977},{"month":3,"riseRate":0.545455,"avgChangeRate":-0.047671},{"month":4,"riseRate":0.416667,"avgChangeRate":0.04499},{"month":5,"riseRate":0.583333,"avgChangeRate":0.041237},{"month":6,"riseRate":0.272727,"avgChangeRate":-0.075756},{"month":7,"riseRate":0.363636,"avgChangeRate":0.040955},{"month":8,"riseRate":0.727273,"avgChangeRate":0.056431},{"month":9,"riseRate":0.181818,"avgChangeRate":-0.108663},{"month":10,"riseRate":0.454545,"avgChangeRate":-0.048106},{"month":11,"riseRate":0.545455,"avgChangeRate":0.268959},{"month":12,"riseRate":0.454545,"avgChangeRate":-0.008306}],"exchange":"NASDAQ","name":"Cellectis SA","nameEN":"Cellectis SA","securityTypeName":"DR","adrRate":"1:1"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Cellectis SA(CLLS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Cellectis SA(CLLS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Cellectis SA,CLLS,Cellectis SA股票,Cellectis SA股票老虎,Cellectis SA股票老虎国际,Cellectis SA行情,Cellectis SA股票行情,Cellectis SA股价,Cellectis SA股市,Cellectis SA股票价格,Cellectis SA股票交易,Cellectis SA股票购买,Cellectis SA股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Cellectis SA(CLLS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Cellectis SA(CLLS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction